Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
0.880
+0.058 (7.06%)
Mar 21, 2025, 4:00 PM EST - Market closed
Bone Biologics Employees
Bone Biologics had 2 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$3,662,462
Market Cap
2.88M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BBLG News
- 5 months ago - Bone Biologics Appoints Phillip T. Meikle to its Board of Directors - Business Wire
- 7 months ago - Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference - Business Wire
- 8 months ago - Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds - Business Wire
- 9 months ago - First Two Patients Treated in Pilot Clinical Study with Bone Biologics' NB1 Bone Graft Device in Spine Fusion - Business Wire
- 1 year ago - Bone Biologics Announces Closing of $2.0 Million Public Offering - Business Wire
- 1 year ago - Bone Biologics Announces Pricing of $2.0 Million Public Offering - Business Wire
- 1 year ago - Bone Biologics Reports Progress With NB1 Clinical Program - Business Wire
- 1 year ago - Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors - Business Wire